DA Versus DAC as Postoperative Adjuvant Treatment for Early-stage Breast Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Our study is a prospective, non-inferior, randomized phase II clinical trial, to compare the
efficacy and safety profiles of DA versus DAC as adjuvant chemotherapy regimens for
early-stage breast cancer patients.